Denmark
· Delayed Price · Currency is DKK Stenocare Statistics
Total Valuation
Stenocare has a market cap or net worth of DKK 7.75 million. The enterprise value is 4.65 million.
| Market Cap | 7.75M |
| Enterprise Value | 4.65M |
Important Dates
The last earnings date was Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Stenocare has 19.98 million shares outstanding.
| Current Share Class | 19.98M |
| Shares Outstanding | 19.98M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.37% |
| Owned by Institutions (%) | n/a |
| Float | 7.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.17 |
| PB Ratio | 3.19 |
| P/TBV Ratio | 3.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.14 |
| EV / Sales | 2.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.66 |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 1.17.
| Current Ratio | 1.72 |
| Quick Ratio | 1.49 |
| Debt / Equity | 1.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.41 |
| Interest Coverage | -24.52 |
Financial Efficiency
Return on equity (ROE) is -266.78% and return on invested capital (ROIC) is -95.27%.
| Return on Equity (ROE) | -266.78% |
| Return on Assets (ROA) | -81.46% |
| Return on Invested Capital (ROIC) | -95.27% |
| Return on Capital Employed (ROCE) | -660.40% |
| Revenue Per Employee | 232,428 |
| Profits Per Employee | -4.10M |
| Employee Count | 8 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 44.18 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.86% in the last 52 weeks. The beta is 0.10, so Stenocare's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -91.86% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 1.41 |
| Relative Strength Index (RSI) | 56.28 |
| Average Volume (20 Days) | 82,543 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Stenocare had revenue of DKK 1.86 million and -32.78 million in losses.
| Revenue | 1.86M |
| Gross Profit | -18.34M |
| Operating Income | -26.12M |
| Pretax Income | -32.64M |
| Net Income | -32.78M |
| EBITDA | -22.72M |
| EBIT | -26.12M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 5.94 million in cash and 2.84 million in debt, giving a net cash position of 3.10 million or 0.16 per share.
| Cash & Cash Equivalents | 5.94M |
| Total Debt | 2.84M |
| Net Cash | 3.10M |
| Net Cash Per Share | 0.16 |
| Equity (Book Value) | 2.43M |
| Book Value Per Share | n/a |
| Working Capital | 3.86M |
Cash Flow
In the last 12 months, operating cash flow was -6.98 million and capital expenditures -44,412, giving a free cash flow of -7.02 million.
| Operating Cash Flow | -6.98M |
| Capital Expenditures | -44,412 |
| Free Cash Flow | -7.02M |
| FCF Per Share | -0.35 |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,404.58% |
| Pretax Margin | -1,755.31% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Stenocare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -422.85% |
| FCF Yield | -90.58% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |